Peers of Gilead Sciences, Inc. (GILD)
Health Care · Biotechnology
Market cap divided by free cash flow over the last 12 months. Shows how many dollars investors pay for each $1 of yearly cash.
Latest P/FCF Ratio
15.09x
As of Nov 3, 2026
Beyond P/FCF Ratio, the valuation view includes forward multiples, EV ratios, cash flow yields, and multi-year chart history for further research.
| Date | P/FCF Ratio |
|---|---|
| Nov 3, 2026 | 15.09x |
| Nov 2, 2026 | 15.34x |
| Oct 30, 2026 | 15.37x |
| Oct 29, 2026 | 14.92x |
| Oct 28, 2026 | 14.34x |
| Oct 27, 2026 | 14.33x |
| Oct 26, 2026 | 14.29x |
| Oct 23, 2026 | 14.05x |
P/FCF Ratio = Market Capitalization / Free Cash Flow (TTM)
P/FCF focuses on actual cash generation rather than accounting profit.
Read the general P/FCF Ratio definition, formula, and analyst usage guide.
P/FCF Ratio guideInformational research only; not personalized advice. Values reflect the latest available data on Chartloom and may differ from other sources.
